Through simultaneously measuring methylation at AHRR as well as a panel of other loci linked to important health outcomes, such as diabetes and obesity (36, 37), it may well be that patients will gain additional motivation to collaborate with their healthcare providers in optimizing their well-being. This evidence concerns the gene AHRR and obesity due to melanocortin 4 receptor deficiency.